CAS: 2130958-55-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AST2818 mesylate REF: AN-AG01EO87CAS: 2130958-55-1 | 99% | 120.00 €~319.00 € | Tue 21 May 24 |
 | Alflutinib mesylate REF: TM-T7175CAS: 2130958-55-1 | 99.81% | 77.00 €~1,662.00 € | Tue 28 May 24 |
 | Ast2818 mesylate REF: 3D-FKD95855CAS: 2130958-55-1 | Min. 95% | To inquire | Mon 01 Jul 24 |
AST2818 mesylate
CAS:2130958-55-1
Formula:
C29H35F3N8O5S
Purity:
99%
Color and Shape:
Solid
Molecular weight:
664.6990
Ref: AN-AG01EO87
| 5mg | 120.00 € | |
| 10mg | 157.00 € | |
| 25mg | 189.00 € | |
| 50mg | 319.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Alflutinib mesylate
CAS:2130958-55-1
Alflutinib mesylate (AST2818 mesylate) ,is an irreversible tyrosine kinase inhibitor that selectively inhibits EGFR mutations, …
Formula:
C29H35F3N8O5S
Purity:
99.81%
Color and Shape:
Solid
Molecular weight:
664.7
Ref: TM-T7175
| 1mg | 77.00 € | |
| 5mg | 160.00 € | |
| 10mg | 230.00 € | |
| 25mg | 388.00 € | |
| 50mg | 576.00 € | |
| 100mg | 816.00 € | |
| 500mg | 1,662.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
Ast2818 mesylate
CAS:2130958-55-1
Ast2818 mesylate is a small-molecule, orally active, selective factor receptor tyrosine kinase inhibitor that targets …
Formula:
C29H35F3N8O5S
Purity:
Min. 95%
Molecular weight:
664.7 g/mol
Ref: 3D-FKD95855
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
